Page last updated: 2024-11-02

pd 98059 and Cataract, Membranous

pd 98059 has been researched along with Cataract, Membranous in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research Excerpts

ExcerptRelevanceReference
"Treatment with andrographolide significantly inhibited phosphorylation of ERK and JNK."1.42Andrographolide suppresses epithelial mesenchymal transition by inhibition of MAPK signalling pathway in lens epithelial cells. ( Arora, A; Gajjar, D; Ganatra, D; Johar, K; Kayastha, F; Madhu, H; Vasavada, A, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kayastha, F1
Johar, K1
Gajjar, D1
Arora, A1
Madhu, H1
Ganatra, D1
Vasavada, A1

Other Studies

1 other study available for pd 98059 and Cataract, Membranous

ArticleYear
Andrographolide suppresses epithelial mesenchymal transition by inhibition of MAPK signalling pathway in lens epithelial cells.
    Journal of biosciences, 2015, Volume: 40, Issue:2

    Topics: Actins; Cataract; Cell Line; Collagen Type IV; Diterpenes; Epithelial Cells; Epithelial-Mesenchymal

2015